Surgery Partners, Inc. (SGRY): Price and Financial Metrics
SGRY Price/Volume Stats
Current price | $29.25 | 52-week high | $45.79 |
Prev. close | $29.28 | 52-week low | $20.46 |
Day low | $28.94 | Volume | 501,758 |
Day high | $29.82 | Avg. volume | 672,321 |
50-day MA | $34.11 | Dividend yield | N/A |
200-day MA | $34.95 | Market Cap | 3.70B |
SGRY Stock Price Chart Interactive Chart >
SGRY POWR Grades
- Growth is the dimension where SGRY ranks best; there it ranks ahead of 97.05% of US stocks.
- The strongest trend for SGRY is in Growth, which has been heading up over the past 177 days.
- SGRY ranks lowest in Momentum; there it ranks in the 14th percentile.
SGRY Stock Summary
- SGRY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 323.64 -- higher than 91.1% of US-listed equities with positive expected earnings growth.
- Of note is the ratio of SURGERY PARTNERS INC's sales and general administrative expense to its total operating expenses; just 17.58% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for SURGERY PARTNERS INC is higher than it is for about 91.65% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to SURGERY PARTNERS INC are FCPT, NFE, SBGI, CTRE, and SOHO.
- SGRY's SEC filings can be seen here. And to visit SURGERY PARTNERS INC's official web site, go to www.surgerypartners.com.
SGRY Valuation Summary
- In comparison to the median Healthcare stock, SGRY's EV/EBIT ratio is 226.72% higher, now standing at 37.9.
- SGRY's price/sales ratio has moved down 0.8 over the prior 97 months.
Below are key valuation metrics over time for SGRY.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
SGRY | 2023-09-22 | 1.4 | 1.9 | -69.8 | 37.9 |
SGRY | 2023-09-21 | 1.4 | 1.9 | -69.7 | 37.9 |
SGRY | 2023-09-20 | 1.5 | 1.9 | -71.1 | 38.4 |
SGRY | 2023-09-19 | 1.4 | 1.9 | -70.6 | 38.2 |
SGRY | 2023-09-18 | 1.5 | 2.0 | -72.9 | 38.9 |
SGRY | 2023-09-15 | 1.5 | 2.0 | -72.6 | 38.8 |
SGRY Growth Metrics
- Its year over year cash and equivalents growth rate is now at -30.08%.
- The 3 year revenue growth rate now stands at 30.38%.
- Its year over year net income to common stockholders growth rate is now at 74.85%.

The table below shows SGRY's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 2,539.3 | 158.8 | -54.6 |
2022-09-30 | 2,442.4 | 171.3 | -31.3 |
2022-06-30 | 2,381 | 156.5 | -29.2 |
2022-03-31 | 2,308.9 | 116.7 | -37.7 |
2021-12-31 | 2,225.1 | 87.1 | -81.2 |
2021-09-30 | 2,163.2 | 76.3 | -85.9 |
SGRY's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- SGRY has a Quality Grade of D, ranking ahead of 15.29% of graded US stocks.
- SGRY's asset turnover comes in at 0.388 -- ranking 64th of 81 Healthcare stocks.
- LHCG, RHE, and ENSG are the stocks whose asset turnover ratios are most correlated with SGRY.
The table below shows SGRY's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.388 | 0.222 | 0.034 |
2021-06-30 | 0.382 | 0.224 | 0.024 |
2021-03-31 | 0.358 | 0.211 | 0.023 |
2020-12-31 | 0.353 | 0.204 | 0.016 |
2020-09-30 | 0.354 | 0.204 | 0.011 |
2020-06-30 | 0.352 | 0.201 | 0.022 |
SGRY Price Target
For more insight on analysts targets of SGRY, see our SGRY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $65.83 | Average Broker Recommendation | 1.38 (Strong Buy) |
Surgery Partners, Inc. (SGRY) Company Bio
Surgery Partners Inc. is a healthcare services company focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of the company's patients and physicians. The company was founded in 2004 and is based in Nashville, Tennessee.
Latest SGRY News From Around the Web
Below are the latest news stories about SURGERY PARTNERS INC that investors may wish to consider to help them evaluate SGRY as an investment opportunity.
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of DirectorsPURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company’s board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the boar |
Teladoc Health welcomes Eric Evans to its board of directorsIn a significant development, Teladoc Health, Inc. (NYSE:TDOC), a global leader in whole-person virtual care, appointed Eric Evans to the company's board of directors today. Mr. Evans, who is currently serving as the Chief Executive Officer and Director of Surgery Partners, Inc. (NASDAQ:NASDAQ:SGRY), will join the board's compensation committee. He steps into this role following the retirement of Senator William Frist, M.D., earlier this year. |
Insider Sell: American Group President Harrison Bane Sells 3,835 Shares of Surgery Partners IncOn September 5, 2023, Harrison Bane, the American Group President of Surgery Partners Inc (NASDAQ:SGRY), sold 3,835 shares of the company. |
Returns At Surgery Partners (NASDAQ:SGRY) Are On The Way UpFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key... |
Zacks Industry Outlook Highlights Medpace, HealthEquity and Surgery PartnersMedpace, HealthEquity and Surgery Partners are part of the Zacks Industry Outlook article. |
SGRY Price Returns
1-mo | -19.20% |
3-mo | -34.99% |
6-mo | -15.14% |
1-year | 17.80% |
3-year | 49.01% |
5-year | 77.27% |
YTD | 4.99% |
2022 | -47.84% |
2021 | 84.11% |
2020 | 85.31% |
2019 | 59.91% |
2018 | -19.09% |
Continue Researching SGRY
Want to see what other sources are saying about Surgery Partners Inc's financials and stock price? Try the links below:Surgery Partners Inc (SGRY) Stock Price | Nasdaq
Surgery Partners Inc (SGRY) Stock Quote, History and News - Yahoo Finance
Surgery Partners Inc (SGRY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...